术前CT引导活检在腹腔及腹膜后肉瘤诊断中的价值
该回顾性研究分析了82例疑似腹腔/腹膜后软组织肿瘤患者,术前CT引导活检与手术病理对照,总体组织学符合率77%。对脂肪肉瘤诊断的敏感度79.3%、特异度100.0%、PPV 100.0%、NPV 89.8%;高分化脂肪肉瘤识别准确率75.0%,去分化脂肪肉瘤仅62.5%。结论认为CT引导活检在专科中心是准确的术前评估工具,但去分化脂肪肉瘤诊断仍具挑战。
要点
- CT引导活检对腹腔脂肪肉瘤特异度达100.0%,可可靠排除非脂肪肉瘤。
- 去分化脂肪肉瘤活检准确率仅62.5%,低于高分化脂肪肉瘤的75.0%。
- 总体组织学符合率77%,其他肉瘤诊断准确率95.5%。
核心结论
- 在专科高容量肉瘤中心,术前CT引导活检是评估腹腔肉瘤尤其是脂肪肉瘤的准确有效方法,为不可或缺的术前治疗决策工具。
- 研究同时证实去分化脂肪肉瘤的诊断困难,而该类患者最可能从新辅助治疗中获益。
研究设计与样本
- 单中心回顾性研究,纳入82例(女35例、男47例,年龄62.0±14.7岁)疑似腹腔腔(含腹膜后)软组织肿瘤患者。
- 所有患者接受术前CT引导活检,随后行手术肿瘤切除,以手术标本最终组织学为参考标准。
- 计算腹部肉瘤患者的敏感度、特异度、PPV和NPV,并对脂肪肉瘤患者进行亚组分析。
诊断标准与关键数值
- CT引导活检总体组织学符合率为77%。
- 脂肪肉瘤:活检诊断23例,手术最终诊断29例;敏感度79.3%、特异度100.0%、PPV 100.0%、NPV 89.8%。
- 脂肪肉瘤亚组:高分化脂肪肉瘤正确识别准确率75.0%,去分化脂肪肉瘤62.5%。
- 其他肉瘤:敏感度87.5%、特异度95.5%、PPV 82.4%、NPV 96.9%、诊断准确率95.5%。
临床应用与阅片要点
- 术前CT引导活检可用于腹腔/腹膜后疑似肉瘤的组织学确诊,尤其脂肪肉瘤特异度高,支持治疗前评估。
- 需警惕去分化脂肪肉瘤活检低估风险,报告时应结合影像特征并建议必要时重复活检或扩大取样。
局限性
- 单中心回顾性设计,样本量有限(82例),结论外推需谨慎。
- 原文未报告活检与手术间隔、活检针具规格及病理复核流程等细节。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
PURPOSE: We aimed to analyze the diagnostic accuracy of preoperative CT-guided biopsy to identify patients that might profit from neoadjuvant chemotherapy in a specialized high-volume sarcoma center.
MATERIAL AND METHODS: We retrospectively reviewed all patients with suspected soft tissue tumors of the abdomen cavity including the retroperitoneum, who received CT-guided biopsy followed by surgical tumor resection. Sensitivity, specificity, PPV and NPV were calculated in all patients with abdominal sarcomas at our hospital. A subgroup analysis was performed for patients with liposarcoma.
RESULTS: A total of 82 patients (35 female, 47 male, age: 62.0 ± 14.7) received preoperative CT-guided biopsy followed by surgical resection. Overall accordance of CT-guided biopsy to identify final histology was 77 %. CT-guided biopsy revealed the diagnosis of liposarcoma in 23 patients whereas final analysis of the surgical specimen identified liposarcoma in 29 patients. Here, sensitivity, specificity, PPV and NPV was 79.3 %, 100.0 %, 100.0 % and 89.8 % respectively. Subgroup analysis revealed a better accuracy for correctly identifying patients with well-differentiated liposarcoma than patients with dedifferentiated liposarcoma (75.0 % vs 62.5 %). In patients with other sarcoma, sensitivity, specificity, PPV, NPV and diagnostic accuracy was 87.5 %, 95.5 %, 82.4 % and 96.9 %, respectively.
CONCLUSION: CT-guided biopsy in a specialized high-volume sarcoma center is an accurate and effective method to assess patients with abdominal sarcoma and especially abdominal liposarcoma. Therefore, it is an indispensable tool in the pretherapeutic workup process. Nevertheless, our study underlines the previously reported difficulties in dedifferentiated liposarcoma diagnostics, whereby these patient cohort would profit the most from a neoadjuvant therapy regime.
引用
- Luca Alatzides, Luisa Steinberg, Schildhaus, et al. Is preoperative CT-guided biopsy a valuable tool in the diagnostic workup of patients with visceral and retroperitoneal sarcoma? Eur J Radiol. 2022. PMID: 35985092. doi:10.1016/j.ejrad.2022.110470
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。